Cree, B. A., Arnold, D. L., Fox, R. J., Gold, R., Vermersch, P., Benedict, R. H., . . . Kappos, L. (2022). Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years. Multiple sclerosis, 28(10), 1591. https://doi.org/10.1177/13524585221083194
Citace podle Chicago (17th ed.)Cree, Bruce Ac, et al. "Long-term Efficacy and Safety of Siponimod in Patients with Secondary Progressive Multiple Sclerosis: Analysis of EXPAND Core and Extension Data Up to >5 years." Multiple Sclerosis 28, no. 10 (2022): 1591. https://doi.org/10.1177/13524585221083194.
Citace podle MLA (9th ed.)Cree, Bruce Ac, et al. "Long-term Efficacy and Safety of Siponimod in Patients with Secondary Progressive Multiple Sclerosis: Analysis of EXPAND Core and Extension Data Up to >5 years." Multiple Sclerosis, vol. 28, no. 10, 2022, p. 1591, https://doi.org/10.1177/13524585221083194.